OR1D3P

Across TCGA pan-cancer cohorts, OR1D3P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated OR1D3P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher OR1D3P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR1D3P expression acts as an unfavorable survival marker, although some lineages such as HNSC and PAAD show a favorable association.

ACC, THCA, and HNSC are the cancer types where OR1D3P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	III,IV	0.300	0.731	<.001	58	view →
THCA	OS	Tertile	II,III,IV	0.133	0.925	<.001	54	view →
HNSC	DFS	Tertile	All	0.804	0.592	.029	12	view →
PAAD	OS	Tertile	All	1.000	0.363	.018	12	view →
COAD	DFS	Tertile	II,III,IV	0.141	0.683	.022	9	view →
PCPG	OS	Tertile	All	0.516	0.946	.044	9	view →
KIRC	DFS	Tertile	IV	0.407	0.661	.042	6	view →
ESCA	OS	Tertile	III,IV	0.623	0.350	.046	6	view →
LGG	OS	Tertile	All	0.708	0.815	.039	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

OR1D3P–ACC (DFS)

Open the ACC breakdown →